{"entity":{"type":"insider","cik":"0001771498","url":"/insider/0001771498","json_url":"/insider/0001771498.json","name":"Shea Jacqueline Elizabeth","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":5,"first":"2021-01-29","last":"2021-06-11","span_basis":"filed_date"},"name_variants":[{"name":"Shea Jacqueline Elizabeth","source":"filing","n_filings":5,"first_seen":"2021-01-29","last_seen":"2021-06-11"}],"transactions":[{"id":5094348,"accession":"0001055726-21-000052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001055726-21-000052","line_url":"/filing/0001055726-21-000052#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001771498","owner_name":"Shea Jacqueline Elizabeth","owner_display_name":"Shea Jacqueline Elizabeth","owner_url":"/insider/0001771498","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38535.0,"shares_display":"38,535","price_per_share":10.01,"price_display":"10.01","price_state":"stated","total_value":385735.35,"total_display":"385,735.35","total_whole":"385,735","shares_owned_after":21592.0,"shares_owned_after_display":"21,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-11","scope":"insider"},{"id":4607987,"accession":"0001055726-21-000034","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001055726-21-000034","line_url":"/filing/0001055726-21-000034#line-3","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001771498","owner_name":"Shea Jacqueline Elizabeth","owner_display_name":"Shea Jacqueline Elizabeth","owner_url":"/insider/0001771498","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4710.0,"shares_display":"4,710","price_per_share":8.97,"price_display":"8.97","price_state":"stated","total_value":42248.7,"total_display":"42,248.70","total_whole":"42,249","shares_owned_after":60127.0,"shares_owned_after_display":"60,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-26","filed_date":"2021-03-26","scope":"insider"},{"id":4513233,"accession":"0001055726-21-000023","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001055726-21-000023","line_url":"/filing/0001055726-21-000023#line-3","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001771498","owner_name":"Shea Jacqueline Elizabeth","owner_display_name":"Shea Jacqueline Elizabeth","owner_url":"/insider/0001771498","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16881.0,"shares_display":"16,881","price_per_share":10.06,"price_display":"10.06","price_state":"stated","total_value":169822.86,"total_display":"169,822.86","total_whole":"169,823","shares_owned_after":55417.0,"shares_owned_after_display":"55,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-12","filed_date":"2021-03-12","scope":"insider"},{"id":4166747,"accession":"0001055726-21-000007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001055726-21-000007","line_url":"/filing/0001055726-21-000007","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001771498","owner_name":"Shea Jacqueline Elizabeth","owner_display_name":"Shea Jacqueline Elizabeth","owner_url":"/insider/0001771498","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28336.0,"shares_display":"28,336","price_per_share":15.047380011293054,"price_display":"15.05","price_state":"stated","total_value":426382.56,"total_display":"426,382.56","total_whole":"426,383","shares_owned_after":44495.0,"shares_owned_after_display":"44,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider","n_lines":2},{"id":4607951,"accession":"0001055726-21-000005","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001055726-21-000005","line_url":"/filing/0001055726-21-000005#line-5","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001771498","owner_name":"Shea Jacqueline Elizabeth","owner_display_name":"Shea Jacqueline Elizabeth","owner_url":"/insider/0001771498","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16713.0,"shares_display":"16,713","price_per_share":12.04,"price_display":"12.04","price_state":"stated","total_value":201224.52,"total_display":"201,224.52","total_whole":"201,225","shares_owned_after":44495.0,"shares_owned_after_display":"44,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-28","filed_date":"2021-01-29","scope":"insider"},{"id":4607944,"accession":"0001055726-21-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001055726-21-000005","line_url":"/filing/0001055726-21-000005","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001771498","owner_name":"Shea Jacqueline Elizabeth","owner_display_name":"Shea Jacqueline Elizabeth","owner_url":"/insider/0001771498","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28336.0,"shares_display":"28,336","price_per_share":12.016309994353472,"price_display":"12.02","price_state":"stated","total_value":340494.16,"total_display":"340,494.16","total_whole":"340,494","shares_owned_after":11920.0,"shares_owned_after_display":"11,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-27","filed_date":"2021-01-29","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001055726","name":"INOVIO PHARMACEUTICALS, INC.","url":"/issuer/0001055726","role":"Officer (Chief Operating Officer)","n_filings":5,"first_seen":"2021-01-29","last_seen":"2021-06-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001771498","retrieved_at":"2026-08-26T18:27:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}